ArticleFrontiers in oncology2026
Epidemiology of bone cancer in Saudi Arabia: a nationwide population-based study (2004-2020).
Article in Frontiers in oncology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
13 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Bone cancer is a rare malignancy worldwide, with incidence patterns that vary by age, sex, and geographic region. In Saudi Arabia, however, comprehensive population-based evidence describing the national epidemiology of bone cancer remains limited. This study aimed to describe bone cancer incidence in Saudi Arabia according to age group, sex, calendar year, and administrative region, with particular emphasis on age-standardized incidence rates (ASIRs). Methods: A retrospective population-based descriptive study was conducted using data from the Saudi Cancer Registry. All primary bone cancer cases diagnosed between 2004 and 2020 were included. Incidence patterns were summarized using frequencies, age-specific incidence rates, crude incidence rates (CIRs), and ASIRs, stratified by sex, age group, year of diagnosis, and region. Statistical analyses were performed using SPSS software version 30. Results: Between 2004 and 2020, a total of 2,275 primary bone cancer cases were recorded in Saudi Arabia, including 1,318 males (57.9%) and 957 females (42.1%). Bone cancer accounted for approximately 2.0% of all cancers among males and 0.9% among females. Mean ASIRs were higher in males (≈1.0 per 100,000) than females (≈0.7 per 100,000), while CIRs remained below 2.0 per 100,000 throughout the study period. Age-specific incidence showed a clear adolescent peak, most prominent in the 15-19-year age group, followed by the 10-14-year group. Regional variation in ASIRs was observed, with higher rates in Al-Jouf and Najran and persistently lower rates in Jazan. Conclusion: Bone cancer in Saudi Arabia is rare but demonstrates distinct variation by sex, age, and region. The observed male predominance and adolescent peak are consistent with international epidemiological patterns. Continued enhancement of population-based cancer surveillance is essential to support accurate epidemiological assessment and informed public health planning.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.